Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
An announcement from Regeneus Ltd. ( (AU:CMB) ) is now available.
Cambium Bio Limited, a company involved in biotechnology, has announced a change in its substantial holding. The company’s voting power has decreased from 20.7% to 13.5% due to a share consolidation and subsequent dilution following a share placement. This change in voting power could impact the company’s influence in decision-making and its strategic direction, affecting stakeholders’ interests.
More about Regeneus Ltd.
YTD Price Performance: -12.50%
Average Trading Volume: 23,974
Technical Sentiment Consensus Rating: Buy
Current Market Cap: A$6.4M
Learn more about CMB stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue